Enhanced Paracrine FGF10 Expression Promotes Formation of Multifocal Prostate Adenocarcinoma and an Increase in Epithelial Androgen Receptor

Fibroblasts in cancer

Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · see citing works

The development of androgen-independent prostate cancer.

Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · see citing works

Stromal fibroblasts in cancer initiation and progression

Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,291 · see citing works

Molecular determinants of resistance to antiandrogen therapy

Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · see citing works

Receptor Specificity of the Fibroblast Growth Factor Family

Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871 · see citing works

Addiction to Oncogenes--the Achilles Heal of Cancer

Weinstein, I. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,753 · see citing works

Simian Sarcoma Virus onc Gene, v- sis , Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth Factor

Doolittle, R. F., Hunkapiller, M. W., Hood, L., Devare, S. G., Robbins, K. C., Aaronson, S. A., & Antoniades, H. N. (1983) · Science · doi:10.1126/science.6304883 · Cited by 1,536 · see citing works

TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401 · see citing works

Fibroblast growth factors, their receptors and signaling

Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070165 · Cited by 1,332 · see citing works

Prostate cancer in a transgenic mouse.

Greenberg, N. M., DeMayo, F. J., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,296 · see citing works

Receptor Specificity of the Fibroblast Growth Factor Family

Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601252200 · Cited by 1,164 · see citing works

Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors

Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163 · see citing works

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109 · see citing works

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938 · see citing works

Essential role for oncogenic Ras in tumour maintenance

Chin, L., Tam, A., Pomerantz, J. H., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 928 · see citing works

Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity

Kousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 749 · see citing works

Mechanisms underlying differential responses to FGF signaling.

Dailey, L., Ambrosetti, D., Mansukhani, A., & Basilico, C. (2005) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2005.01.007 · Cited by 701 · see citing works

Versatile retroviral vectors for potential use in gene therapy.

Hawley, R. G., Lieu, F. H., Fong, A. Z. C., & Hawley, T. S. (1994) · PubMed · Cited by 652 · see citing works

Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee

Shappell, S. B., THOMAS, G. V., Roberts, R. L., Herbert, R. A., Ittmann, M., Rubin, M. A., Humphrey, P. A., Sundberg, J. P., Rozengurt, N., Barrios, R. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0946 · Cited by 598 · see citing works

Reversibility of acute B-cell leukaemia induced by BCR–ABL1

Huettner, C. S., Zhang, P., Etten, R. A. V., & Tenen, D. G. (2000) · Nature Genetics · doi:10.1038/71691 · Cited by 413 · see citing works

The role of fibroblast growth factors and their receptors in prostate cancer

Kwabi‐Addo, B., Özen, M., & Ittmann, M. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00535 · Cited by 350 · see citing works

Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis

Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324 · see citing works

The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild‐type and androgen‐insensitive (Tfm) Mice

Cunha, G. R., & Lung, B. (1978) · Journal of Experimental Zoology · doi:10.1002/jez.1402050203 · Cited by 303 · see citing works

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model

Majumder, P., Yeh, J.-J., George, D., Febbo, P., Kum, J., Xue, Q., Bikoff, R., Ma, H.-K., Kantoff, P., Golub, T., et al. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1232229100 · Cited by 299 · see citing works

Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks

Cheng, N., Bhowmick, N. A., Chytil, A. M., Gorksa, A. E., Brown, K. A., Muraoka, R. S., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 268 · see citing works

Androgen receptors in prostate cancer.

Čulig, Z., Klocker, H., Bartsch, G., & Hobisch, A. (2002) · Endocrine Related Cancer · doi:10.1677/erc.0.0090155 · Cited by 247 · see citing works

An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors

Dong, B., Kim, S., Hong, S., Gupta, J. D., Malathi, K., Klein, E. A., Ganem, D., DeRisi, J. L., Chow, S. A., & Silverman, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610291104 · Cited by 219 · see citing works

Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.

Scher, H. I., Sarkis, A. S., Reuter, V., Cohen, D., Netto, G. J., Petrylak, D. P., LIANES, P., FUKS, Z. Y., Mendelsohn, J. M., & Cordon‐Cardo, C. (1995) · PubMed · Cited by 214 · see citing works

Post-translational modifications of steroid receptors

Faus, H., & Haendler, B. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.082 · Cited by 210 · see citing works

Prostatic growth and development are regulated by FGF10

Thomson, A. A., & Cunha, G. R. (1999) · Development · doi:10.1242/dev.126.16.3693 · Cited by 209 · see citing works

In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme

Xin, L., Ide, H., Kim, Y. H., Dubey, P., & Witte, O. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734139100 · Cited by 195 · see citing works

Fibroblast Growth Factor-10

Lu, W., Luo, Y., Kan, M., & McKeehan, W. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12827 · Cited by 191 · see citing works

Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation

Boxer, R. B., Jang, J. W.-U., Sintasath, L., & Chodosh, L. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.013 · Cited by 178 · see citing works

Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.

Feng, S., Wang, F., Matsubara, A., Kan, M., & McKeehan, W. L. (1997) · PubMed · Cited by 173 · see citing works

FGF-10 plays an essential role in the growth of the fetal prostate

Donjacour, A. A., Thomson, A. A., & Cunha, G. R. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00250-1 · Cited by 170 · see citing works

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor

Xin, L., Teitell, M. A., Lawson, D. A., Kwon, A., Mellinghoff, I. K., & Witte, O. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602567103 · Cited by 160 · see citing works

Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections

Zambrano, A., Kalantari, M., Simoneau, A. R., Jensen, J. L., & Villarreal, L. P. (2002) · The Prostate · doi:10.1002/pros.10157 · Cited by 152 · see citing works

Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.

Gao, H., Ouyang, X., Banach-Petrosky, W. A., Gerald, W. L., Shen, M. M., & Abate-Shen, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606836103 · Cited by 141 · see citing works

Androgen receptor - an update of mechanisms of action in prostate cancer

Čulig, Z., Hobisch, A., Bartsch, G. C., & Klocker, H. (2000) · Urological Research · doi:10.1007/s002400000111 · Cited by 124 · see citing works

Selective over‐expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer

Sahadevan, K., Darby, S., Leung, H. Y., Mathers, M. E., Robson, C. N., & Gnanapragasam, V. J. (2007) · The Journal of Pathology · doi:10.1002/path.2205 · Cited by 115 · see citing works

Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.

Matsubara, A., Kan, M., Feng, S., & McKeehan, W. L. (1998) · PubMed · Cited by 107 · see citing works

Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis

Lin, Y., Liu, G., Zhang, Y., Hu, Y.-P., Yu, K., Lin, C., McKeehan, K. A., Xuan, J. W., Ornitz, D. M., Shen, M. M., et al. (2007) · Development · doi:10.1242/dev.02765 · Cited by 106 · see citing works

Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer.

Bostwick, D. G., & Foster, C. S. (1999) · PubMed · Cited by 88 · see citing works

Detection and expression of human BK virus sequences in neoplastic prostate tissues

Das, D., Shah, R. B., & Imperiale, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207920 · Cited by 88 · see citing works

Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.

Freeman, K. W., Welm, B. E., Gangula, R., Rosen, J. M., Ittmann, M., Greenberg, N. M., & Spencer, D. M. (2003) · PubMed · Cited by 86 · see citing works

Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma

Vukovic, B., Park, P. C., Al-Maghrabi, J. A., Beheshti, B., Sweet, J., Evans, A., Trachtenberg, J., & Squire, J. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206227 · Cited by 86 · see citing works

Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone‐refractory prostate cancer

Reddy, G. P. V., Barrack, E. R., Dou, Q. P., Menon, M., Pelley, R. P., Sarkar, F. H., & Sheng, S. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20927 · Cited by 79 · see citing works

Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma Microenvironment

Seftor, E. A., Brown, K. M., Chin, L., Kirschmann, D. A., Wheaton, W. W., Protopopov, A. I., Feng, B., Balagurunathan, Y., Trent, J. M., Nickoloff, B. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2497 · Cited by 75 · see citing works

Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations

Wong, S., McLaughlin, J., Cheng, D., Zhang, C., Shokat, K. M., & Witte, O. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407061101 · Cited by 72 · see citing works

Cell Transformation by Fibroblast Growth Factors Can Be Suppressed by Truncated Fibroblast Growth Factor Receptors

Li, Y., Basilico, C., & Mansukhani, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7660 · Cited by 71 · see citing works

Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis

Zhong, C., Saribekyan, G., Liao, C., Cohen, M. B., & Roy‐Burman, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3440 · Cited by 69 · see citing works

Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression

Huss, W. J., Barrios, R. J., Foster, B. A., & Greenberg, N. M. (2002) · The Prostate · doi:10.1002/pros.10163 · Cited by 61 · see citing works

Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice

Foster, B. A., Evangelou, A. I., Kaplan, P. J., DeMayo, F. J., Greenberg, N. M., & Gingrich, J. R. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700915.x · Cited by 54 · see citing works

Androgen-Stimulated Human Prostate Epithelial Growth Mediated by Stromal-Derived Fibroblast Growth Factor-10.

Nakano, K., Fukabori, Y., Itoh, N., Lu, W., Kan, M., McKeehan, W. L., & Yamanaka, H. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.405 · Cited by 51 · see citing works

Growth Factors, Growth-Factor Receptors and Oncogenes

Kris, R., Libermann, T. A., Avivi, A., & Schlessinger, J. (1985) · Nature Biotechnology · doi:10.1038/nbt0285-135 · Cited by 30 · see citing works

REGULATION OF KERATINOCYTE GROWTH FACTOR RECEPTOR AND ANDROGEN RECEPTOR IN EPITHELIAL CELLS OF THE HUMAN PROSTATE

Planz, B., Wang, Q., Kirley, S. D., Marberger, M., & McDougal, W. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66042-9 · Cited by 29 · see citing works

Prostate tumor progression and prognosis

Harding, M. A., & Theodorescu, D. (2000) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(00)00073-9 · Cited by 17 · see citing works

Cell Transformation by Fibroblast Growth Factors Can Be Suppressed by Truncated Fibroblast Growth Factor Receptors

Li, Y., Basilico, C., & Mansukhani, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7660-7669.1994 · Cited by 17 · see citing works

Fibroblast growth factor signalling: from development to cancer

Turner, N., & Grose, R. (2010) · Nature Reviews. Cancer · doi:10.1038/nrc2780 · Cited by 2,689 · see citing works

The Fibroblast Growth Factor signaling pathway

Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050 · see citing works

Molecular genetics of prostate cancer: new prospects for old challengesPreprint

Shen, M. M., & Abate-Shen, C. T. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 949 · see citing works

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

Karantanos, T., Corn, P. G., & Thompson, T. C. (2013) · Oncogene · doi:10.1038/onc.2013.206 · Cited by 866 · see citing works

Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures

Karthaus, W. R., Iaquinta, P. J., Drost, J., Gracanin, A., van Boxtel, R., Wongvipat, J., Dowling, C., Gao, D., Begthel, H., Sachs, N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.017 · Cited by 720 · see citing works

New horizons in tumor microenvironment biology: challenges and opportunities

Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0278-7 · Cited by 704 · see citing works

Fibroblast growth factors and their receptors in cancer

Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 535 · see citing works

Craniopharyngioma

Muller, H. L., Merchant, T. E., Warmuth‐Metz, M., Martı́nez-Barberá, J. P., & Puget, S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0125-9 · Cited by 526 · see citing works

Androgen receptors in hormone-dependent and castration-resistant prostate cancer

Shafi, A. A., Yen, A. E., & Weigel, N. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.003 · Cited by 422 · see citing works

Bone metastasis: mechanisms and therapeutic opportunities

Suva, L. J., Washam, C. L., Nicholas, R. W., & Griffin, R. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.227 · Cited by 423 · see citing works

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

Lee, J. K., Phillips, J. W., Smith, B. A., Park, J. W., Stoyanova, T. I., McCaffrey, E., Baertsch, R., Sokolov, A., Meyerowitz, J., Mathis, C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.001 · Cited by 410 · see citing works

Nice Neighborhood: Emerging Concepts of the Stem Cell Niche

Scadden, D. T. (2014) · Cell · doi:10.1016/j.cell.2014.02.013 · Cited by 342 · see citing works

Roles of Fibroblast Growth Factor Receptors in Carcinogenesis

Haugsten, E. M., Więdłocha, A., Olsnes, S., & Wesche, J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0168 · Cited by 315 · see citing works

Tissue-specific tumorigenesis: context matters

Schneider, G., Schmidt‐Supprian, M., Rad, R., & Saur, D. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.5 · Cited by 312 · see citing works

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Zhu, M.-L., & Kyprianou, N. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0084 · Cited by 286 · see citing works

Basal epithelial stem cells are efficient targets for prostate cancer initiation

Lawson, D. A., Yang, Z., Memarzadeh, S., Li, X., Huang, J.-T., & Witte, O. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0913873107 · Cited by 291 · see citing works

Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation

Lukacs, R. U., Memarzadeh, S., Wu, H., & Witte, O. N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.11.013 · Cited by 268 · see citing works

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

He, Y., Xu, W., Xiao, Y., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 275 · see citing works

Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee

Ittmann, M., Huang, J., Radaelli, E., Martin, P., Signoretti, S., Sullivan, R., Simons, B. W., Ward, J. M., Robinson, B. D., Chu, G. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4213 · Cited by 231 · see citing works

TGF‐β regulates isoform switching of FGF receptors and epithelial–mesenchymal transition

Shirakihara, T., Horiguchi, K., Miyazawa, K., Ehata, S., Shibata, T., Morita, I., Miyazono, K., & Saitoh, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.351 · Cited by 225 · see citing works

Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance

Cao, Z., Ding, B., Guo, P., Lee, S. B., Butler, J. M., Casey, S. C., Simons, M., Tam, W., Felsher, D. W., Shido, K., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.005 · Cited by 224 · see citing works

Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy

Johansson, A., Rudolfsson, S. H., Hammarsten, P., Bergström, S. H., Pietras, K., Jones, J., Stattin, P. E., Egevad, L., Granfors, T., Wikström, P., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100070 · Cited by 216 · see citing works

ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells

Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203 · see citing works

Prostate organogenesis: tissue induction, hormonal regulation and cell type specification

Toivanen, R., & Shen, M. M. (2017) · Development · doi:10.1242/dev.148270 · Cited by 204 · see citing works

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach

Presta, M., Chiodelli, P., Giacomini, A., Rusnati, M., & Ronca, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.013 · Cited by 199 · see citing works

A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models

Zhao, G., Li, W.-Y., Chen, D., Henry, J. R., Li, H., Chen, Z., Zia‐Ebrahimi, M., Bloem, L. J., Zhai, Y. W., Huss, K., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0306 · Cited by 196 · see citing works

Mechanisms of FGFR-mediated carcinogenesis

Ahmad, I., Iwata, T., & Leung, H. Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.004 · Cited by 185 · see citing works

Paracrine roles of cellular senescence in promoting tumourigenesis

Gonzalez-Meljem, J. M., Apps, J. R., Fraser, H. C., & Martinez-Barbera, J. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0066-1 · Cited by 183 · see citing works

Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers

Tiong, K. H., Mah, L. Y., & Leong, C. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0886-7 · Cited by 179 · see citing works

Neuron and microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κB-dependent neuroinflammation to improve functional recovery after spinal cord injury

Chen, J., Wang, Z., Zheng, Z., Chen, Y., Khor, S., Shi, K., He, Z., Wang, Q., Zhao, Y., Zhang, H., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.490 · Cited by 176 · see citing works

Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer

Schaeffer, E. M., Marchionni, L., Huang, Z., Simons, B. W., Blackman, A., Yu, W., Parmigiani, G., & Berman, D. M. (2008) · Oncogene · doi:10.1038/onc.2008.327 · Cited by 167 · see citing works

The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis

Bonollo, F., Thalmann, G. N., Julio, M. K., & Karkampouna, S. (2020) · Cancers · doi:10.3390/cancers12071887 · Cited by 169 · see citing works

Refining the role for adult stem cells as cancer cells of origin

White, A. C., & Lowry, W. E. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.08.008 · Cited by 155 · see citing works

Immunosenescence: signaling pathways, diseases and therapeutic targets

Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 157 · see citing works

Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine

Praharaj, P. P., Bhutia, S. K., Nagrath, S., Bitting, R. L., & Deep, G. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.005 · Cited by 147 · see citing works

Paths of FGFR-driven tumorigenesis

Acevedo, V. D., Ittmann, M., & Spencer, D. M. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7657 · Cited by 145 · see citing works

Beneficial and detrimental effects of human endogenous retroviruses

Kurth, R., & Bannert, N. (2009) · International Journal of Cancer · doi:10.1002/ijc.24902 · Cited by 137 · see citing works

Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient

Mulholland, T., McAllister, M. J., Patek, S., Flint, D., Underwood, M., Sim, A., Edwards, J., & Zagnoni, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33055-0 · Cited by 133 · see citing works

Targeting the fibroblast growth factor receptor family in cancer

Hallinan, N., Finn, S. P., Cuffe, S. D., Rafee, S., O'Byrne, K. J., & Gately, K. A. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.03.015 · Cited by 125 · see citing works

Molecular pathways and targets in prostate cancer

Shtivelman, E., Beer, T. M., & Evans, C. P. (2014) · Oncotarget · doi:10.18632/oncotarget.2406 · Cited by 115 · see citing works

FGFR1 Is Essential for Prostate Cancer Progression and Metastasis

Yang, F., Zhang, Y., Ressler, S. J., Ittmann, M., Ayala, G. E., Dang, T. D., Wang, F., & Rowley, D. R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3274 · Cited by 108 · see citing works

Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment

Nguyen, E. V., Pereira, B. A., Lawrence, M. G., Ma, X., Rebello, R. J., Chan, H., Niranjan, B., Wu, Y., Ellem, S., Guan, X., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001496 · Cited by 107 · see citing works

Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer

Kim, S., Kim, N., Dong, B.-H., Boren, D., Lee, S. A., das Gupta, J., Gaughan, C., Klein, E., Lee, C., Silverman, R., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01299-08 · Cited by 119 · see citing works

Targeting Fibroblast Growth Factor Pathways in Prostate Cancer

Corn, P. G., Wang, F., McKeehan, W. L., & Navone, N. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1550 · Cited by 99 · see citing works

Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy

Cai, H., Babić, I., Wei, X. X., Huang, J., & Witte, O. N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1605 · Cited by 96 · see citing works

Selecting causal genes from genome-wide association studies via functionally coherent subnetworks

Taşan, M., Musso, G. A., Hao, T., Vidal, M., MacRae, C. A., & Roth, F. P. (2014) · Nature Methods · doi:10.1038/nmeth.3215 · Cited by 97 · see citing works

Prostate cancer cell–stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases

Wan, X., Corn, P. G., Yang, J., Palanisamy, N., Starbuck, M. W., Efstathiou, E., Tapia, E. M. L. N., Zurita, A. J., Aparicio, A. M., Ravoori, M. K., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009332 · Cited by 96 · see citing works

Patterns of scAAV Vector Insertion Associated With Oncogenic Events in a Mouse Model for Genotoxicity

Rosas, L. E., Grieves, J. L., Zaraspe, K., Perle, K. M. D. L., Fu, H., & McCarty, D. M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.197 · Cited by 95 · see citing works

Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer

Drake, J. M., Lee, J. K., & Witte, O. N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-13 · Cited by 93 · see citing works

The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis

Ronca, R., Giacomini, A., Rusnati, M., & Presta, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1062475 · Cited by 89 · see citing works

Differential transformation capacity of Src family kinases during the initiation of prostate cancer

Cai, H., Smith, D. A., Memarzadeh, S., Lowell, C. A., Cooper, J. A., & Witte, O. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103904108 · Cited by 89 · see citing works

Fibroblast growth factors, old kids on the new block

Li, X., Wang, C., Xiao, J., McKeehan, W. L., & Wang, F. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.12.014 · Cited by 89 · see citing works

Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling

Zong, Y., Huang, J., Sankarasharma, D., Morikawa, T., Fukayama, M., Epstein, J. I., Chada, K. K., & Witte, O. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217982109 · Cited by 87 · see citing works

Blocking the FGF/FGFR system as a two-compartment antiangiogenic/antitumor approach in cancer therapy

Giacomini, A., Chiodelli, P., Matarazzo, S., Rusnati, M., Presta, M., & Ronca, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.024 · Cited by 87 · see citing works

Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis

Ricke, E. A., Williams, K., Lee, Y., Couto, S. S., Wang, Y. Z., Hayward, S. W., Cunha, G. R., & Ricke, W. A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs153 · Cited by 83 · see citing works

Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy

Janzen, D. M., Rosales, M. A., Paik, D. Y., Lee, D. S., Smith, D. A., Witte, O. N., Iruela‐Arispe, M. L., & Memarzadeh, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0930 · Cited by 82 · see citing works

The FGF/FGFR system in the physiopathology of the prostate gland

Giacomini, A., Grillo, E., Rezzola, S., Ribatti, D., Rusnati, M., Ronca, R., & Presta, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00005.2020 · Cited by 80 · see citing works

Sonic hedgehog signals to multiple prostate stromal stem cells that replenish distinct stromal subtypes during regeneration

Peng, Y., Levine, C. M., Zahid, S., Wilson, E. L., & Joyner, A. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315729110 · Cited by 76 · see citing works

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention

Wang, Y., Liu, D., Zhang, T., & Xia, L. (2021) · Cancers · doi:10.3390/cancers13061360 · Cited by 76 · see citing works

Structural Biology of the FGF7 Subfamily

Zinkle, A., & Mohammadi, M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00102 · Cited by 74 · see citing works

Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype

Murphy, T., Darby, S., Mathers, M. E., & Gnanapragasam, V. J. (2009) · The Journal of Pathology · doi:10.1002/path.2657 · Cited by 74 · see citing works

Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer

Ronca, R., Alessi, P., Coltrini, D., Salle, E. D., Giacomini, A., Leali, D., Corsini, M., Belleri, M., Tobia, C., Garlanda, C., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4181 · Cited by 72 · see citing works

Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage

Seo, E., Basu-Roy, U., Zavadil, J., Basilico, C., & Mansukhani, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05798-11 · Cited by 72 · see citing works

Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts

Zhao, W.-M., Wang, L., Park, H., Chhim, S., Tanphanich, M., Yashiro, M., & Kim, K. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0531 · Cited by 72 · see citing works

Three-dimensional bio-printing: A new frontier in oncology research

Charbe, N. B., McCarron, P. A., & Tambuwala, M. M. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i1.21 · Cited by 69 · see citing works

In vitro modeling of the prostate cancer microenvironment

Ellem, S. J., De-Juan-Pardo, E. M., & Risbridger, G. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.008 · Cited by 68 · see citing works

Cell types of origin for prostate cancer

Lee, S. H., & Shen, M. M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.002 · Cited by 66 · see citing works

The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis

Ganguly, S. S., Li, X., & Miranti, C. K. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00364 · Cited by 66 · see citing works

Biological Significance and Targeting of the FGFR Axis in Cancer

Chioni, A., & Grose, R. (2021) · Cancers · doi:10.3390/cancers13225681 · Cited by 58 · see citing works

Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium

Memarzadeh, S., Zong, Y., Janzen, D. M., Goldstein, A. S., Cheng, D., Kurita, T., Schafenacker, A. M., Huang, J., & Witte, O. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012548107 · Cited by 63 · see citing works

A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer

Crowley, F., Sterpi, M., Buckley, C. W., Margetich, L., Handa, S., & Dovey, Z. (2021) · Research and Reports in Urology · doi:10.2147/rru.s264722 · Cited by 58 · see citing works

Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ

Huang, Z., Marsiglia, W. M., Roy, U. B., Rahimi, N., Ilghari, D., Wang, H., Chen, H., Gai, W., Blais, S. P., Neubert, T. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.010 · Cited by 59 · see citing works

Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer

Owen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 57 · see citing works

Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development

Frank, S. B., & Miranti, C. K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00273 · Cited by 50 · see citing works

Foxp1-mediated programming of limb-innervating motor neurons from mouse and human embryonic stem cells

Adams, K. L., Rousso, D. L., Umbach, J. A., & Novitch, B. G. (2015) · Nature Communications · doi:10.1038/ncomms7778 · Cited by 50 · see citing works

Expression of the Bcl-2 Protein BAD Promotes Prostate Cancer Growth

Smith, A. J., Karpova, Y., D'Agostino, R., Willingham, M. C., & Kulik, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006224 · Cited by 50 · see citing works

Mesenchymal mechanisms in prostate organogenesis

Thomson, A. A. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00296.x · Cited by 50 · see citing works

Serum Cytokine Profile in Patients With Pancreatic Cancer

Torres, C., Perales, S., Alejandre, M. J., Iglesias, J., Palomino‐Morales, R., Martı́n, M., Caba, O., Prados, J. C., Aránega, A., Delgado, J. R., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000155 · Cited by 49 · see citing works

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure

Grindstad, T., Andersen, S., Al‐Saad, S., Dønnem, T., Kiselev, Y., Melbø‐Jørgensen, C., Skjefstad, K., Busund, L., Bremnes, R. M., & Richardsen, E. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116691 · Cited by 49 · see citing works

Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer

Hofmann, S., Cohen-Harazi, R., Maizels, Y., & Koman, I. E. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-1577 · Cited by 47 · see citing works

Src: Marker or Actor in Prostate Cancer Aggressiveness

Vlaeminck‐Guillem, V., Gillet, G., & Rimokh, R. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00222 · Cited by 46 · see citing works

Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis

González-Meljem, J. M., & Martı́nez-Barberá, J. P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03798-7 · Cited by 47 · see citing works

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia

Hata, J., Harigane, Y., Matsuoka, K., Akaihata, H., Yaginuma, K., Meguro, S., Hoshi, S., Sato, Y., Ogawa, S., Uemura, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411634 · Cited by 44 · see citing works

Overexpression of FGF9 in Prostate Epithelial Cells Augments Reactive Stroma Formation and Promotes Prostate Cancer Progression

Huang, Y., Jin, C., Hamana, T., Liu, J., Wang, C., An, L., McKeehan, W. L., & Wang, F. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12468 · Cited by 42 · see citing works

Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome

Meng, Q. H., Xu, E., Hildebrandt, M. A. T., Liang, D., Lu, K. H., Ye, Y., Wagar, E. A., & Wu, X. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.211490 · Cited by 42 · see citing works

High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer

Barreiro-Alonso, A., Maceiras, M. L., Rodriguez-Belmonte, E. M., Vizoso‐Vázquez, Á., Quindós, M., & Cerdán, M. E. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5845061 · Cited by 41 · see citing works

Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal

Memarzadeh, S., Cai, H., Janzen, D. M., Xin, L., Lukacs, R. U., Riedinger, M., Zong, Y., Gendt, K. D., Verhoeven, G., Huang, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105243108 · Cited by 38 · see citing works

Wnt Inhibitory Factor 1 (Wif1) Is Regulated by Androgens and Enhances Androgen-Dependent Prostate Development

Keil, K. P., Mehta, V., Branam, A. M., Abler, L. L., Buresh‐Stiemke, R. A., Joshi, P. S., Schmitz, C. T., Marker, P. C., & Vezina, C. M. (2012) · Endocrinology · doi:10.1210/en.2012-1564 · Cited by 39 · see citing works

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

Choi, Y. J., Kim, H. S., Park, S. H., Kim, B. S., Kim, K. H., Lee, H. J., SONG, H. S., Shin, D., Lee, H. Y., Kim, H., et al. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2017.438 · Cited by 39 · see citing works

Emerging Roles of Fibroblast Growth Factor 10 in Cancer

Clayton, N. S., & Grose, R. P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00499 · Cited by 39 · see citing works

Hedgehog signaling in prostate epithelial–mesenchymal growth regulation

Peng, Y., & Joyner, A. L. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.01.019 · Cited by 38 · see citing works

Computational modeling and simulation of genital tubercle development

Leung, M. C. K., Hutson, M. S., Seifert, A. W., Spencer, R. M., & Knudsen, T. B. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.05.005 · Cited by 37 · see citing works

Potential involvement of Fgf10/Fgfr2 and androgen receptor (AR) in renal fibrosis in adult male rat offspring subjected to prenatal exposure to di- n -butyl phthalate (DBP)

Sun, W.-L., Zhu, Y., Ni, X., Jing, D.-D., Yao, Y., Ding, W., Liu, Z.-H., Ding, G.-X., & Jiang, J. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.09.009 · Cited by 37 · see citing works

Influence of stromal–epithelial interactions on androgen action

Nieto, C., Rider, L. C., & Cramer, S. D. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0138 · Cited by 37 · see citing works

“Topological Significance” Analysis of Gene Expression and Proteomic Profiles from Prostate Cancer Cells Reveals Key Mechanisms of Androgen Response

Vellaichamy, A., Dezső, Z., JeBailey, L., Chinnaiyan, A. M., Sreekumar, A., Nesvizhskii, A. I., Omenn, G. S., & Bugrim, A. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010936 · Cited by 35 · see citing works

TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth

Jeong, J. H., Bhatia, A., Toth, Z., Oh, S., Inn, K., Liao, C., Roy‐Burman, P., Melamed, J., Coetzee, G. A., & Jung, J. U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016205 · Cited by 34 · see citing works

A New Therapy Paradigm for Prostate Cancer Founded on Clinical Observations

Efstathiou, E., & Logothetis, C. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1215 · Cited by 34 · see citing works

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer

Ronca, R., Tamma, R., Coltrini, D., Ruggieri, S., Presta, M., & Ribatti, D. (2017) · Oncotarget · doi:10.18632/oncotarget.19773 · Cited by 33 · see citing works

Does the microenvironment influence the cell types of origin for prostate cancer?Preprint

Goldstein, A. S., & Witte, O. N. (2013) · Genes & Development · doi:10.1101/gad.222380.113 · Cited by 33 · see citing works

Small-Molecule Protein Tyrosine Kinase Inhibitors for the Treatment of Metastatic Prostate Cancer

Gallick, G. E., Corn, P. G., Zurita, A. J., & Lin, S.-H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.161 · Cited by 32 · see citing works

Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression

Li, Q., Ingram, L. M., Kim, S., Beharry, Z. M., Cooper, J. A., & Cai, H. (2018) · Neoplasia · doi:10.1016/j.neo.2018.01.006 · Cited by 17 · see citing works

Emerging Roles of Fibroblast Growth Factor 10 in Cancer

Clayton, N. S., & Grose, R. P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00499 · Cited by 39 · see citing works

The role of fibroblast growth factors and their receptors in prostate cancer

Kwabi‐Addo, B., Özen, M., & Ittmann, M. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00535 · Cited by 350 · see citing works

Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition

Brooks, J. D. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.07.010 · Cited by 11 · see citing works

Androgen-Stimulated Human Prostate Epithelial Growth Mediated by Stromal-Derived Fibroblast Growth Factor-10.

Nakano, K., Fukabori, Y., Itoh, N., Lu, W., Kan, M., McKeehan, W. L., & Yamanaka, H. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.405 · Cited by 51 · see citing works